Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV ...(ationsinterested in licensing the HIV uH...),Health

Date:9/17/2007

ations interested in licensing the HIV uHTS assay should contact Trana at info@tranadiscovery.com or by calling 866-390-3452 (toll free) or +1-919-342-6192. Parties also interested in outsourcing screening using this assay may contact David Harris at Southern Research at d.harris@southernresearch.org or call 1-800-967-6774.

About Southern Research Institute

Southern Research Institute is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery and drug development, advanced engineering, environmental research and energy production. To date, Southern Research has discovered six FDA-approved cancer drugs and discovered sox additional drugs that are currently in late stage preclinical and early clinical trials. No other company or institution has brought six of its own cancer drug discoveries to market. For more information, please visit http://www.southernresearch.org.

About Trana Discovery, Inc.

Trana Discovery is a drug discovery company whose technology identifies compounds that interrupt the lifecycle of pathogens through a novel mechanism of action -- the inhibition of transfer RNA (tRNA). The company enables exclusive rights to new classes of drugs used to treat serious bacterial, fungal and viral infectious diseases. The use of Trana Discovery technology can unlock the value -- human and financial -- hidden in drug compound libraries and can shorten the time between drug discovery and availability. Trana Discovery is commercializing technology that has been under development for nearly 20 years at North Carolina State University. The company is located in Cary, North Carolina. For more information, please visit http://www.tranadiscovery.com.

Media Contacts:

Karl von Gunten (919) 931-1434 Rhonda Jung (205) 581-2317

SOURCE Southern Research Institute Copyright©2007 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
2. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
3. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
4. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
5. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
6. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
7. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
8. Discoverys KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
9. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies Annual Meeting
10. Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
11. Southern Research Institute to Present at the 2007 American Association For Cancer Research Annual Meeting